orphenadrine has been researched along with Abnormalities, Drug-Induced in 1 studies
Orphenadrine: A muscarinic antagonist used to treat drug-induced parkinsonism and to relieve pain from muscle spasm.
orphenadrine : A tertiary amino compound which is the phenyl-o-tolylmethyl ether of 2-(dimethylamino)ethanol.
Abnormalities, Drug-Induced: Congenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother, or to which she is inadvertently exposed during the manufacture of such substances. The concept excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beall, JR | 1 |
1 other study available for orphenadrine and Abnormalities, Drug-Induced
| Article | Year |
|---|---|
A teratogenic study of chlorpromazine, orphenadrine, perphenzaine, and LSD-25 in rats.
Topics: Abnormalities, Drug-Induced; Animals; Birth Weight; Chlorpromazine; Embryo Implantation; Evaluation | 1972 |